Liberty Wealth Management LLC Buys New Position in HCA Healthcare, Inc. $HCA

Liberty Wealth Management LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 4,079 shares of the company’s stock, valued at approximately $1,905,000.

Other hedge funds have also modified their holdings of the company. Holos Integrated Wealth LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at about $29,000. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $26,000. Ares Financial Consulting LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at about $31,000. Aventura Private Wealth LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at approximately $34,000. Finally, Key Capital Management INC acquired a new stake in HCA Healthcare during the 4th quarter valued at approximately $35,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.50% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. Stephens lowered their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Barclays lowered their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. KeyCorp lowered their price objective on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Finally, The Goldman Sachs Group lifted their target price on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $517.82.

Get Our Latest Stock Analysis on HCA

HCA Healthcare Trading Up 0.9%

Shares of HCA opened at $430.11 on Wednesday. The firm has a market cap of $95.42 billion, a price-to-earnings ratio of 14.79, a PEG ratio of 1.35 and a beta of 1.18. The stock has a 50 day moving average of $485.46 and a 200-day moving average of $486.47. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the previous year, the business posted $6.45 EPS. HCA Healthcare’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is currently 10.73%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.